183 related articles for article (PubMed ID: 24456315)
1. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
[TBL] [Abstract][Full Text] [Related]
2. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
Peaslee A; Wickizer M; Olson J; Topp R
J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction.
Kogut SJ; Johnson S; Higgins T; Quilliam B
J Manag Care Pharm; 2012 May; 18(4):297-310. PubMed ID: 22548690
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
5. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
6. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
7. Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
Duru OK; Turk N; Ettner SL; Neugebauer R; Moin T; Li J; Kimbro L; Chan C; Luchs RH; Keckhafer AM; Kirvan A; Ho S; Mangione CM
J Gen Intern Med; 2015 Nov; 30(11):1645-50. PubMed ID: 25944019
[TBL] [Abstract][Full Text] [Related]
8. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
9. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
Johnson JT; Neill KK; Davis DA
J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
[TBL] [Abstract][Full Text] [Related]
10. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
[TBL] [Abstract][Full Text] [Related]
11. Impact of a value-based formulary in three chronic disease cohorts.
Yeung K; Basu A; Marcum ZA; Watkins JB; Sullivan SD
Am J Manag Care; 2017 Mar; 23(3 Suppl):S46-S53. PubMed ID: 29648740
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?
Sacks NC; Burgess JF; Cabral HJ; McDonnell ME; Pizer SD
J Manag Care Spec Pharm; 2015 Aug; 21(8):678-87. PubMed ID: 26233540
[TBL] [Abstract][Full Text] [Related]
13. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.
Zeng F; An JJ; Scully R; Barrington C; Patel BV; Nichol MB
Value Health; 2010; 13(6):846-52. PubMed ID: 20561344
[TBL] [Abstract][Full Text] [Related]
14. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of value-based insurance design with a large retail employer.
Kim YA; Loucks A; Yokoyama G; Lightwood J; Rascate K; Serxner SA
Am J Manag Care; 2011 Oct; 17(10):682-90. PubMed ID: 22106461
[TBL] [Abstract][Full Text] [Related]
16. Impact of a patient-centered pharmacy program and intervention in a high-risk group.
Moore JM; Shartle D; Faudskar L; Matlin OS; Brennan TA
J Manag Care Pharm; 2013 Apr; 19(3):228-36. PubMed ID: 23537457
[TBL] [Abstract][Full Text] [Related]
17. Association Between Supplemental Nutrition Assistance Program Participation and Cost-Related Medication Nonadherence Among Older Adults With Diabetes.
Pooler JA; Srinivasan M
JAMA Intern Med; 2019 Jan; 179(1):63-70. PubMed ID: 30453334
[TBL] [Abstract][Full Text] [Related]
18. Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing.
Henk HJ; Lopez JMS; Bookhart BK
J Manag Care Spec Pharm; 2018 Sep; 24(9):847-855. PubMed ID: 30156451
[TBL] [Abstract][Full Text] [Related]
19. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
[No Abstract] [Full Text] [Related]
20. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
